AtriCure (ATRC) Reports In-Line Q3 EPS; Guides FY15 Revenue Above Consensus
Get Alerts ATRC Hot Sheet
Price: $62.48 --0%
EPS Growth %: -300.0%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
EPS Growth %: -300.0%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $31.4 million versus the consensus estimate of $31.38 million.
AtriCure sees FY2015 revenue of $129.5-130.5 million, versus the consensus of $128.6 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regal-Beloit (RBC) Tops Q3 EPS by 21c ; Offers Guidance
- nVent Electric (NVT) Tops Q3 EPS by 13c ; Offers Guidance
- Lear Corp. (LEA) Tops Q3 EPS by 39c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share